Product Name | Glucagon - Like Peptide 1, GLP - 1 (7 - 36), amide, humanHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR - NH2 |
Size | 1 mg |
Catalog # | AS-22463 |
US$ | $238 |
Purity | % Peak Area By HPLC ≥ 95% |
GLP-1 (7-36) amide is an incretin hormone that causes glucose dependent release of insulin by pancreaticbeta cells.It is the cleavage product of GLP-1 (1-36) amide peptide (Cat# AS-22460).Both GLP-1 (7-36) andGLP-1 (7-37)-Cat# AS-20761, also play roles in gastric motility (gastric emptying), on the suppression of plasma glucagon levels (glucose production) and possibly on the promotion of satiety and stimulation of glucose disposal in peripheral tissues independent of the actions of insulin.GLP-1 (7-36) has a short half life of less than 2 minutes, and like GIP, is rapidly degraded by the enzyme dipeptidyl peptidase IV (DPP-4),which is widely expressed in a number of sites, including the endothelial cells of small gut arterioles.DPP-4 degrades GLP-1 (7-36) into the non insulinotropic GLP-1 (9-36)-Cat# AS-65070 (some studies suggest it may have weak insulinotropic activity). As a result, the majority of GLP-1 (and GIP) is inactivated as an insulinotrope before reaching the systemic circulation. | |
Detailed Information | DatasheetMaterial Safety Data Sheets (MSDS) |
Storage | -20°C |
References | Drucker, D. et al. Proc Natl Acad Sci USA 84, 3434 (1987) Kieffer, T. and J. Habener, Endo Rev 20, 876 (1999)Deacon, CF. et. al. Hormone Metabolic Res 36,761 (2004), doi: 10.1055/s-2004-826160Williams, JA. Pancreadepedia (2014), doi: 10.3998/panc.2014.7Elahi, D. et. al. Obesity (Silver Spring) 16, 1501 (2008), doi: 10.1038/oby.2008.229Ban, K. et. al. Endocrinol 151, 1520 (2010), doi: http://dx.doi.org/10.1210/en.2009-1197 |
Molecular Weight | 3297.7 |
HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 | |
Sequence(Three-Letter Code) | H - His - Ala - Glu - Gly - Thr - Phe - Thr - Ser - Asp - Val - Ser - Ser - Tyr - Leu - Glu - Gly - Gln - Ala - Ala - Lys - Glu - Phe - Ile - Ala - Trp - Leu - Val - Lys - Gly - Arg - NH2 |
Product Citations | Tashiro Y et al. (2014) A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis; Peptides 54, 19-26. Puddu A et al. (2010) Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15. Biochem Biophys Res Commun 398, 462. |
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
有以下三种效应:
1.空穴效应
被柱塞压缩的物料内积聚了极高的能量,通过限流缝隙时瞬间失压,造成高能释放引起空穴爆炸,致使物料强烈粉碎细化。
2.撞击效应
物料通过限流缝隙时以上述极高的速度撞击到特制的碰撞环上,造成物料粉碎。
3.剪切效应
高速物料通过阀腔通道和限流缝隙时会产生强烈的剪切。
主要应用于乳品、果汁等的稳定和悬浮,通过细化脂肪、蛋白、纤维等大颗粒,来达到体系稳定的效果。
均质机的作用主要有:提高产品的均匀度和稳定性;增加保质期;减少反应时间从而节省大量催化剂或添加剂;改变产品的稠度改善产品的口味和色泽等等
高速匀浆机是一种特殊的匀浆机,其采用可控硅高速度的调节系统,霍尔元件测速采用了先进的电子线路,数字显示清晰,使用方便。主要用于动物,植物组织匀浆粉碎,细胞分散。 高速匀浆机设计合理,结构新颖,采用优质高速电机,无级变速,装有稳压系统,转速显示稳定。具有功率大、噪音小,操作安全等特点,为各大中院校、科研单位、化工等实验室、搅拌各种液相化学反应提供一项不可缺少的基本设备
国内均质阀一般用耐腐蚀硬质合金、陶瓷和司太立合金等。国外用碳化钛不锈钢钢结硬质合金。不锈钢钢结硬质合金
均质机是通过柱塞的往复运动产生的高压,均质机用来做细胞破碎,分散乳化
匀浆机就是把动植物组织打散并研磨成均匀的糊状物的机器
自己再找度娘解释一下名词吧
我说的太详细有点像做广告的嫌疑
额定压力范围 0-150Mpa (0-20000psi)
2、额定流量
3、额定频率
额定柱塞频率 >30次/分钟,无增压器,多见于大多数欧州产,加拿大和国产的均质机系列
4、降温系统
5、控制系统
6、重量和外形尺寸向左转|向右转
暂无品牌问答